Uricosuric effect of losartan in patients with renal transplants

Transplantation

Volumn 72, Issue 4, 2001, Pages 671-674

  Kamper, Anne Lise ^a,b   Nielsen, Arne Høj ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CYCLOSPORIN A; LOSARTAN; POTASSIUM; URIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; HYPERURICOSURIA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

EID: 0035959369     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200108270-00019     Document Type: Article

References (21)

1. Cyclosporine-induced hyperuvicemia and gout
2. Impairment of tubular secretion of urate in renal transplant patients on cyclosporine
3. Regulation of renal urate excretion: A critical review
4. Uric acid as an independent risk factor in the treatment of hypertension
5. Pilot study of the uricosuric effect of DuP-753, a new Ang II receptor antagonist, in healthy subjects
6. Salt-dependent renal effects of an angiotensin II antagonists in healthy subjects
7. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension
8. Effects of losartan on renal function in patients with essential hypertension
9. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension
10. Effect of the angiotensin II antagonist losartan in hypertensive patients with renal disease
11. Efficacy and tolerability of losartan in hypertensive patients with renal impairment
12. Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients
13. Renal effects of angiotensin II receptor blockade in normotensive subjects
14. Losartan in renal allograft recipients receiving cyclosporine A
15. Long-term antiproteinuric effect of losartan in renal transplant recipients treated for hypertension
16. Pharmacodynamic activity of intravenous E 3174, an angiotensin II antagonist in patients with essential hypertension
17. Short-term and sustained renal effects of angiotensin II receptor blockade in healthy subjects
18. Urate transport in brush-border membrane of human kidney
19. Effect of losartan on hemoglobin concentration in renal transplant recipients - A retrospective analysis
20. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis
21. Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: A prospective study